GlyCOVID

GlyCOVID is a dataset of RDFized COVID-19 data related to glycans. Resources will be added incrementally as publications are curated.

Longitudinal Development of Antibody Responses in COVID-19 Patients of Different Severity with ELISA, Peptide, and Glycan Arrays: An Immunological Case Series.
Heidepriem J, et al.
Pathogens. 2021; 10(4):438. https://doi.org/10.3390/pathogens10040438

A longitudinal analysis of three COVID-19 patients with moderate (#1) and mild disease (#2 and #3) was published. Antibody serum responses were analyzed using spike glycoprotein enzyme linked immunosorbent assay (ELISA), full-proteome peptide, and glycan microarrays. In this Glycovid dataset, the data from these glycan microarray experiments have been RDFized. Fluorescence intensity is given in arbitrary fluorescence units (AFU) as reported in this publication.

Source Last Updated
PSICQUIC March 30, 2022
Displaying entries 2276 - 2300 of 4050 in total
Antibody Patient Onset (days) Symptom GlyTouCan ID ▼ Arbitrary Fluorescence Units (AFU)
IgM Patient 3 11 mild
G37036SF
7951
IgM Patient 3 4 mild
G37036SF
7526
IgA Patient 4 12 mild
G37036SF
410
IgG Patient 4 12 mild
G37036SF
166
IgM Patient 4 12 mild
G37036SF
106
IgA Patient 1 10 moderate
G36544AC
430
IgA Patient 1 22 moderate
G36544AC
496
IgA Patient 1 6 moderate
G36544AC
392
IgG Patient 1 10 moderate
G36544AC
32
IgG Patient 1 22 moderate
G36544AC
51
IgM Patient 1 10 moderate
G36544AC
90
IgM Patient 1 22 moderate
G36544AC
305
IgA Patient 2 15 mild
G36544AC
897
IgA Patient 2 24 mild
G36544AC
1165
IgG Patient 2 15 mild
G36544AC
213
IgG Patient 2 24 mild
G36544AC
256
IgM Patient 2 15 mild
G36544AC
665
IgM Patient 2 24 mild
G36544AC
935
IgG Patient 1 6 moderate
G36544AC
32
IgM Patient 1 6 moderate
G36544AC
95
IgA Patient 2 3 mild
G36544AC
1007
IgG Patient 2 3 mild
G36544AC
258
IgM Patient 2 3 mild
G36544AC
623
IgA Patient 3 -180 mild
G36544AC
267
IgA Patient 3 11 mild
G36544AC
457

About Release Notes Help Feedback

Click here to visit the beta site.


International Collaboration

GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.

Acknowledgements

Supported by JST NBDC Grant Number JPMJND2204

Partly supported by NIH Common Fund Grant #1U01GM125267-01


Logo License Policies Site Map

Contact: support@glycosmos.org

This work is licensed under Creative Commons Attribution 4.0 International


GlyCosmos Portal v4.0.0

Last updated: August 19, 2024